A debriding gel in the treatment of post-trauma, non-healing lesions
- PMID: 37455802
- PMCID: PMC10349327
A debriding gel in the treatment of post-trauma, non-healing lesions
Abstract
Background: Topical desiccation agent (TDA) is an acidic species in a gel with a potent hygroscopic action. When in contact with (water in) biofilm and necrosis, rapid desiccation occurs, with the dehydrated tissues typically sloughing off in 1-3 days. This allows for quick granulation tissue formation which is an essential step for healing by secondary intention or as wound bed preparation for grafting.
Methods: A series of nine non-healing, post-trauma lesions on the lower leg were treated with TDA, followed by treatment of the lesion with vaseline gauze.
Results: The average age of the patients was 77.0 years and the lesions had been in existence for 5.6 months on average. The average size of the lesion was 15.9 cm2. Complete granulation of all lesions was reached in an average of 34.1 days while the time to complete reepithelialization averaged, 69.8 days (data from one outlier removed). There were no adverse events.
Conclusion: These data suggest TDA treatment is an effective and efficient way to debride lesions, and to prepare them for healing by secondary intention or for grafting.
Keywords: Debridement; desiccation; granulation; non-healing; post-trauma lesion.
IJBT Copyright © 2023.
Conflict of interest statement
The author is consultant to DEBx Medical, Amsterdam, the Netherlands.
Figures
Similar articles
-
A desiccation compound as a biofilm- and necrosis-removing agent: a case series.J Wound Care. 2022 Oct 2;31(10):816-822. doi: 10.12968/jowc.2022.31.10.816. J Wound Care. 2022. PMID: 36240800
-
Biofilm management using monofilament fibre debridement technology: outcomes and clinician and patient satisfaction.J Wound Care. 2019 Sep 2;28(9):608-622. doi: 10.12968/jowc.2019.28.9.608. J Wound Care. 2019. PMID: 31513491
-
Efficacy and tolerance of calcium alginate versus vaseline gauze dressings in the treatment of diabetic foot lesions.Diabetes Metab. 2002 Jun;28(3):223-9. Diabetes Metab. 2002. PMID: 12149603 Clinical Trial.
-
Wound care in venous ulcers.Phlebology. 2013 Mar;28 Suppl 1:79-85. doi: 10.1177/0268355513477015. Phlebology. 2013. PMID: 23482540 Review.
-
Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.Health Technol Assess. 2000;4(21):1-237. Health Technol Assess. 2000. PMID: 11074391 Review.
References
-
- Pugliese DJ. Infection in venous leg ulcers: considerations for optimal management in the elderly. Drugs Aging. 2016;33:87–96. - PubMed
-
- Situm M, Kolic M, Redzepi G, Antolic S. Chronic wounds as a public health problem. Acta Med Croatica. 2014;68(Suppl 1):5–7. - PubMed
-
- Raffetto JD. Pathophysiology of wound healing and alterations in venous leg ulcers-review. Phlebology. 2016;31(Suppl):56–62. - PubMed
-
- Raffetto JD. Pathophysiology of chronic venous disease and venous ulcers. Surg Clin North Am. 2018;98:337–347. - PubMed
LinkOut - more resources
Full Text Sources